Abstract
Alloreactivity is the strongest known primary immune response. Its clinical manifestations are graft rejection, graft-versus-host disease and graft-versus-leukemia effect. The strongest stimulation by allogeneic cells is due to incompatibility at the major histocompatibility complex (MHC) genes. However, the non-MHC genes also participate in allogeneic response. Here we present a mouse model for study of the role of non-MHC genes in regulation of alloreactivity and show that they besides encoding antigens also regulate the responsiveness. Recombinant congenic strains (RCS) of O20/A (O20)-c-B10.O20/Dem (OcB/Dem) series have been derived from the parental strains O20 and B10.O20, which carry identical MHC haplotypes (H2pz) and therefore their differences in alloantigen response depend only on non-MHC genes. We have tested a MLR response by spleen cells of the strains O20, B10.O20, and 16 OcB/Dem strains through stimulation by cells from strains C57BL/10 (H2b), BALB/c (H2d), CBA (H2k), and DBA/1 (H2q) alloantigens. Proliferative response of O20, B10.O20 and OcB/Dem strains to these four alloantigens exhibited a similar but not completely identical pattern of reactivity. The responses to different alloantigens were highly correlated: C57BL/10-BALB/c r = 0.87, C57BL/10-CBA r = 0.84, C57BL/10-DBA/1 r = 0.83. Cluster analysis of the responses by O20, B10.O20, and OcB mice identified groups of strains with distinct patterns of response. This data shows that two main types of genes influence MLR: 1. structural genes for major and minor alloantigens and 2. genes regulating T-cell receptor signal transduction or mediating costimulatory signals by antigen-presenting cells.
Similar content being viewed by others
Abbreviations
- GVHD:
-
graft-versus-host-disease
- IL:
-
interleukin
- MHC:
-
major histocompatibility complex
- MLR:
-
mixed lymphocyte response
- MLC:
-
mixed lymphocyte culture
- RCS:
-
recombinant congenic strains
- TGF:
-
transforming growth factor
- TNF:
-
tumor necrosis factor
- QTL:
-
quantitative trait loci
References
S. Friedman, D. Sillcocks and H. Cantor: “Alloreactivity of an OVA-specific T-cell clone. I. Stimulation by class II MHC and novel non-MHC B-cell determinants”, Immunogenetics, Vol. 26, (1987), pp. 193–203.
T.E. Starzl, T.L. Marchioro, J.H. Holmes, G. Hermann, R.S. Brittain, O.H. Stonington, D.W. Talmage and W.R. Waddell: “Renal homografts in patients with major donor-recipient blood group incompatibilities”, Surgery, Vol. 55, (1964), pp. 195–200.
V. Lenhard, B. Hansen, D. Roelcke, K. Dreikorn, P. Wernet, H. Bockhorn, W. Fassbinder, R.F. Fetta, H. Wilms, B. Gumbel, F.W. Albert, R.W. Ewald, I. Sprenger-Klasen and S.F. Goldmann: “Influence of Lewis and other blood group systems in kidney transplantation”, Proc. Eur. Dial. Transplant. Assoc., Vol. 19, (1983), pp. 432–437.
J.C. Gluckman, C. Foucault, H. Beaufils, J. Luciani, J. Cartron and P.F. Frantz: “Rh antibodies after kidney transplantation”, Transplantation, Vol. 32, (1981), pp. 260–262.
E. Spierings, B. Wieles and E. Goulmy: “Minor histocompatibility antigens—big in tumour therapy”, Trends Immunol. Vol. 25, (2004), pp. 56–60.
A.J. Barrett, K. Rezvani, S. Solomon, A.M. Dickinson, X.N. Wang, G. Stark, H. Cullup, M. Jarvis, P.G. Middleton and N. Chao: “New developments in allotransplant immunology”, Hematology (Am. Soc. Hematol. Educ. Program), (2003), pp. 350-371.
S.M. Katz, M. Liebert, T. J. Gill III, H.W. Kunz, D.V. Cramer and R.D. Guttmann: “The relative roles of MHC and non-MHC genes in heart and skin allograft survival”, Transplantation, Vol. 36, (1983), pp. 96–101.
A.R. Youssef, C. Otley, P.W. Mathieson and R.M. Smith: “Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities”, Transpl. Immunol., Vol. 13, (2004), pp. 297–304.
Z. Haskova, T.J. Sproule, D.C. Roopenian and A.B. Ksander: “An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection”, Transplantation, Vol. 75, (2003), pp. 1368–1374.
K. Rao, R.D. Lund, H.W. Kunz and T.J. Gill III: “The role of MHC and non-MHC antigens in the rejection of intracerebral allogeneic neural grafts”, Transplantation, Vol. 48, (1989), pp. 1018–1021.
B. Korngold and J. Sprent: “Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow”, J. Exp. Med., Vol. 148, (1978), pp. 1687–1698.
C.S. Via and G.M. Shearer: “T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease”, Immunol. Today, Vol. 9, (1988), pp. 207–213.
I. Miconnet, T. Roger, M. Seman and M. Bruley-Rosset: “Critical role of endogenous Mtv in acute lethal graft-versus-host disease”, Eur. J. Immunol., Vol. 25, (1995), pp. 364–368.
S.C. Muluk, F.T. Hakim and G.M. Shearer: “Regulation of graft-versus-host reaction by Mlsa-reactive donor T cells”, Eur. J. Immunol., Vol. 22, (1992), pp. 1967–1973.
R.A. Mann, A.B. Singh, M. Singh and A.E. Jetzt: “The host response in graft-versus-host disease. II. The emergence of host protective cells is in part determined by background genomic compatibility”, Cell. Immunol., Vol. 151, (1993), pp. 39–51.
H. Havelková, J. Badalová, P. Demant and M. Lipoldová: “A new type of genetic regulation of allogeneic response. A novel locus on mouse chromosome 4, Alan2 controls MLC reactivity to three different alloantigens: C57BL/10, BALB/c and CBA”, Genes Immun., Vol. 1, (2000), pp. 483–487.
V. Holáň, H. Havelková, M. Krulová, P. Demant and M. Lipoldová: “A novel alloreactivity controlling locus, Alan1 mapped to mouse chromosome 17”, Immunogenetics, Vol. 51, (2000), pp. 755–757.
R.D. Allen, J.A. Dobkins, J.M. Harper and D.L. Slayback: “Genetics of graft-versus-host disease, I. A locus on chromosome 1 influences development of acute graft-versus-host disease in a major histocompatibility complex mismatched murine model”, Immunology, Vol. 96, (1999), pp. 254–261.
L.D. Fast: “Identification of a single non-H2 gene regulating graft-versus-host disease response”, J. Immunol., Vol. 144 (1990), pp. 4177–4182.
J.M. Harper, D.L. Slayback, J.A. Dobkins and R.D. Allen: “A locus on chromosome 2 influences the development of acute graft-versus-host disease in a murine model”, Bone Marrow Transplant., Vol. 23, (1999), pp. 1183–1190.
D.L. Slayback, J.A. Dobkins, J.M. Harper and R.D. Allen: “Genetic factors influencing the development of chronic graft-versus-host disease in a murine model”, Bone Marrow Transplant., Vol. 26, (2000), pp. 931–938.
M. Rychlíková, P. Demant and P. Ivanyi: “The mixed lymphocyte reaction in H2K, H2D, and non-H2 incompatibility”, Biomedicine, Vol. 18, (1973), pp. 401–407.
M. Berger, P.J. Wettstein and R. Korngold: “T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens”, Transplantation, Vol. 57, (1994), pp. 1095–1102.
M.A. Williams, J. Trambley, J. Ha, A.B. Adams, M.M. Durham, P. Rees, S.R. Cowan, T.C. Pearson and C.P. Larsen: “Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts”, J. Immunol., Vol. 165, (2000), pp. 6849–6857.
P. Demant and A.A.M. Hart: “Recombinant congenic strains: a new tool for analyzing genetic traits determined by more than one gene”, Immunogenetics, Vol. 24, (1986), pp. 416–422.
M. Lipoldová, M. Kosařová, A. Zajícová, V. Holáň, A.A.M. Hart, M. Krulová and P. Demant: “Separation of multiple genes controlling the T cell proliferative response to IL-2 and anti-CD3 using Recombinant Congenic Strains”, Immunogenetics, Vol. 41, (1995), pp. 301–311.
M. Kosařová, H. Havelková, M. Krulová, P. Demant and M. Lipoldová: “The production of two Th2 cytokines, interleukin-4 and interleukin-10, is controlled independently by locus Cypr1 and by loci Cypr2 and Cypr3 respectively”, Immunogenetics, Vol. 49, (1999), pp. 134–141.
H. Havelková, M. Kosařová, M. Krulová, P. Demant and M. Lipoldová: “T-cell proliferative response is controlled by loci Tria4 and Tria5 on mouse chromosomes 7 and 9”, Mamm. Genome, Vol. 10, (1999), pp. 670–674.
M. Lipoldová, H. Havelková, J. Badalová and P. Demant: “Novel loci controlling lymphocyte proliferative response to cytokines and their clustering with loci controlling autoimmune reactions, macrophage function, and lung tumor susceptibility”, Int. J. Cancer, Vol. 114, (2005), pp. 394–399.
R.J. Fijneman, M. Vos, J. Berkhof, P. Demant and G. Kraal: “Genetic analysis of macrophage characteristics as a tool to identify tumor susceptibility genes: mapping of three macrophage-associated risk inflammatory factors, marif1, marif2, and marif3”, Cancer Res., Vol. 64, (2004), pp. 3458–3464.
G.E. Franco, S.J. Litscher, T.K. O’Neil, M. Piette, P. Demant and R.D. Blank: “Dual energy X ray absorptiometry of ex vivo HcB/Dem mouse long bones: left are denser than right”, Calcif. Tissue Int., Vol. 76, (2005) pp. 26–31.
V.V. Colinayo, J.H. Qiao, P. Demant, K. Krass, A.J. Lusis and T.A. Drake: “Genetic characterization of the Dyscalc locus”, Mamm. Genome, Vol. 13, (2002), pp. 283–288.
P. Demant, M. Lipoldová and M. Svobodová: “Resistance to Leishmania major in mice”, Science, Vol. 274, (1996), pp. 1392–1393.
M. Lipoldová, M. Svobodová, M. Krulová, H. Havelková, J. Badalová, E. Nohýnková, V. Holáň, A.A.M. Hart, P. Volf and P. Demant: “Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes”, Genes Immun., Vol. 1, (2000), pp. 200–206.
M. Lipoldová, M. Svobodová, H. Havelková, M. Krulová, J. Badalová, E. Nohýnková, A.A.M. Hart, D. Schlegel, P. Volf and P. Demant: “Mouse genetic model for clinical and immunological heterogeneity of leishmaniasis”, Immunogenetics, Vol. 54, (2002), pp. 174–183.
V. Vladimirov, J. Badalová, M. Svobodová, H. Havelková, A.A.M. Hart, H. Blažková, P. Demant and M. Lipoldová: “Different genetic control of cutaneous and visceral disease after Leishmania major infection in mouse”, Infect. Immun., Vol. 71, (2003), pp. 2041–2046.
R.J.A. Fijneman, S.S. de Vries, R.C. Jansen and P. Demant: “Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3 and Sluc4 that influence susceptibility to lung cancer in the mouse”, Nature Genet., Vol. 14, (1996), pp. 465–467.
T. van Wezel, A.P. Stassen, C.J. Moen, A.A.M. Hart, M.A. van der Valk and P. Demant: “Gene interaction and single gene effects in colon tumour susceptibility in mice”, Nat. Genet., Vol. 14, (1996), pp. 468–470.
P. Demant: “Cancer susceptibility in the mouse: genetics, biology and implications for human cancer”, Nat. Rev. Genet., Vol. 4, (2003), pp. 721–734.
J.S. Bodnar, A. Chatterjee, L.W. Castellani, D.A. Ross, J. Ohmen, J. Cavalcoli, C. Wu, K.M. Dains, J. Catanese, M. Chu, S.S. Sheth, K. Charugundla, P. Demant, D.B. West, P. de Jong and A.J. Lusis: “Positional cloning of the combined hyperlipidemia gene Hyplip1”, Nat. Genet., Vol. 30, (2002), pp. 110–116.
A.J. Van Oosterhout, P.V. Jeurink, P.C. Groot, G.A. Hofman, F.P. Nijkamp and P. Demant: “Genetic analysis of antigen-induced airway manifestations of asthma using recombinant congenic mouse strains”, Chest, Vol. 121, (2002) p. 13S.
V. Holáň, M. Lipoldová and P. Demant: “Identical genetic control of MLC reactivity to different MHC incompatibilities, independent of production and response to IL-2”, Immunogenetics, Vol. 44, (1996), pp. 27–35.
A. Czarnomska and P. Demant: “H-2 antigenic specificities controlled by the translocation chromosome T190”, Transplantation, Vol. 30, (1980), pp. 69–72.
J. Klein: “Immunologically important loci”, In: M. Lyon and A.G. Searle (eds.): Genetic variants and strains of the laboratory mouse, 2nd ed., Oxford University Press, Oxford, 1989, pp. 797–825.
A.P.M. Stassen, P.C. Groot, J.T. Eppig and P. Demant: “Genetic composition of the recombinant congenic strains” Mamm. Genome, Vol. 7, (1996), pp. 55–58.
J.H. Ward: “Hierarchical Grouping to Optimize an Objective Function”, J. Am. Stat. Assoc., Vol. 58, (1963), pp. 236–244.
J.A. Hartigan: Clustering algorithms, J. Wiley, New York, 1975.
R.J. Fijneman, M.A. van der Valk and P. Demant: “Genetics of quantitative and qualitative aspects of lung tumorigenesis in the mouse: multiple interacting Susceptibility to lung cancer (Sluc) genes with large effects”, Exp. Lung Res., Vol. 24, (1998), pp. 419–436.
Author information
Authors and Affiliations
About this article
Cite this article
Havelková, H., Holáň, V., Kárník, I. et al. Mouse model for analysis of non-MHC genes that influence allogeneic response: recombinant congenic strains of OcB/Dem series that carry identical H2 locus. cent.eur.j.biol. 1, 16–28 (2006). https://doi.org/10.2478/s11535-006-0002-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.2478/s11535-006-0002-x